argenx SE | ARGX - Current Liabilities

Stock Price
713.60
Daily Change
9.80 1.39%
Monthly
4.39%
Yearly
12.34%
Q1 Forecast
686.63

argenx SE reported $1.04B in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
AstraZeneca USD 34.05B 518M Sep/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Qiagen NV USD 973.4M 154.91M Sep/2025
UCB EUR 3.53B 731M Dec/2024